← FDA Drug Approvals (Drugs@FDA)
TRI-LINYAH
ANDA · Abbreviated New Drug Application (Generic) · Sponsor: NOVAST LABS LTD · Approved 2012-05-30
Drug application
- FDA Application #
ANDA090524
- Application type
- Abbreviated New Drug Application (Generic)
- Brand name
- TRI-LINYAH
- Generic name
- NORGESTIMATE AND ETHINYL ESTRADIOL
- Active ingredients
- ETHINYL ESTRADIOL; NORGESTIMATE
- Dosage form
- TABLET
- Route
- ORAL-28
- Marketing status
- Prescription
- Sponsor
- NOVAST LABS LTD
- Manufacturer
- Northstar Rx LLC
- First approval
- 2012-05-30
Source
- Authoritative
- Drugs@FDA application overview
- Machine
- JSON-LD · Markdown